Literature DB >> 15136901

Cardiac failure in hemolytic uremic syndrome and rescue with extracorporeal life support.

N J Thomas1, J J Messina, W J DeBruin, J A Carcillo.   

Abstract

Extrarenal involvement manifesting in the cardiovascular system is a rare but potentially fatal complication of hemolytic uremic syndrome (HUS). Current treatment is aimed at cardiovascular supportive measures while awaiting organ recovery. However, there are cases in which this recovery never occurs, and patients succumb secondary to heart failure. We report two cases of severe cardiac failure in children in the acute phase of HUS and the use of extracorporeal membrane oxygenation (ECMO) to support one patient to cardiac recovery. Clinicians should be aware of this potentially life-threatening cardiac involvement and should consider the use of ECMO for potentially salvageable children with HUS.

Entities:  

Mesh:

Year:  2005        PMID: 15136901     DOI: 10.1007/s00246-004-0708-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  12 in total

Review 1.  Management of hemolytic-uremic syndrome.

Authors:  R L Siegler
Journal:  J Pediatr       Date:  1988-06       Impact factor: 4.406

Review 2.  Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome.

Authors:  R L Siegler
Journal:  J Pediatr       Date:  1994-10       Impact factor: 4.406

3.  A clinicopathological study of 24 children with hemolytic uremic syndrome. A report of the Southwest Pediatric Nephrology Study Group.

Authors:  J C Argyle; R J Hogg; T J Pysher; F G Silva; R L Siegler
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

4.  Dilated cardiomyopathy associated with haemolytic uraemic syndrome.

Authors:  J Poulton; C M Taylor; J V De Giovanni
Journal:  Br Heart J       Date:  1987-02

5.  Extracorporeal membrane oxygenation in the management of cardiac failure secondary to myocarditis.

Authors:  B R Cofer; B W Warner; A Stallion; F C Ryckman
Journal:  J Pediatr Surg       Date:  1993-05       Impact factor: 2.545

Review 6.  ECMO in the management of cardiac failure.

Authors:  J B Zwischenberger; C S Cox
Journal:  ASAIO J       Date:  1992 Oct-Dec       Impact factor: 2.872

7.  The importance of nonrenal involvement in hemolytic-uremic syndrome.

Authors:  K Upadhyaya; K Barwick; M Fishaut; M Kashgarian; N J Siegel
Journal:  Pediatrics       Date:  1980-01       Impact factor: 7.124

8.  Extracorporeal membrane oxygenator rescue in children during cardiac arrest after cardiac surgery.

Authors:  P J del Nido; H J Dalton; A E Thompson; R D Siewers
Journal:  Circulation       Date:  1992-11       Impact factor: 29.690

9.  Extracorporeal membrane oxygenation in children after cardiac surgery.

Authors:  S C Raithel; D G Pennington; E Boegner; A Fiore; T R Weber
Journal:  Circulation       Date:  1992-11       Impact factor: 29.690

Review 10.  Circulatory support in infants and children.

Authors:  D G Pennington; M T Swartz
Journal:  Ann Thorac Surg       Date:  1993-01       Impact factor: 4.330

View more
  8 in total

1.  Extra-corporeal membrane oxygenation and Eculizumab: Atypical treatments for typical haemolytic uraemic syndrome.

Authors:  Matthew D Kelham; Liam Gleeson; Inma Alcalde; Rosalba Spiritoso; Alastair G Proudfoot; Marie Scully
Journal:  J Intensive Care Soc       Date:  2019-03-07

Review 2.  Direct cardiac involvement in childhood hemolytic-uremic syndrome: case report and review of the literature.

Authors:  Davide Rigamonti; Giacomo D Simonetti
Journal:  Eur J Pediatr       Date:  2016-09-23       Impact factor: 3.183

3.  HUS-induced cardiac and circulatory failure is reversible using cardiopulmonary bypass as rescue.

Authors:  René F Andersen; Jesper V Bjerre; Johan V Povlsen; Mette Veien; Konstantinos Kamperis; Søren Rittig
Journal:  Pediatr Nephrol       Date:  2017-08-05       Impact factor: 3.714

4.  Cardiac Manifestation among Children with Hemolytic Uremic Syndrome.

Authors:  Emily Sanders; Clare C Brown; Richard T Blaszak; Brendan Crawford; Parthak Prodhan
Journal:  J Pediatr       Date:  2021-04-02       Impact factor: 6.314

5.  Transient severe metastatic calcification in acute renal failure.

Authors:  Daniel Landau; Hanna Krymko; Hanna Shalev; Svetlana Agronovich
Journal:  Pediatr Nephrol       Date:  2006-12-21       Impact factor: 3.714

Review 6.  Extra-renal manifestations of complement-mediated thrombotic microangiopathies.

Authors:  Johannes Hofer; Alejandra Rosales; Caroline Fischer; Thomas Giner
Journal:  Front Pediatr       Date:  2014-09-08       Impact factor: 3.418

7.  Acute Systolic Heart Failure Associated with Complement-Mediated Hemolytic Uremic Syndrome.

Authors:  John L Vaughn; Jared M Moore; Spero R Cataland
Journal:  Case Rep Hematol       Date:  2015-10-18

Review 8.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.

Authors:  Adrien Joseph; Aurélie Cointe; Patricia Mariani Kurkdjian; Cédric Rafat; Alexandre Hertig
Journal:  Toxins (Basel)       Date:  2020-01-21       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.